Your niche is too specific for the analyst firms and too small to staff a research team. Tensorust finds the exact public record your question lives in, connects it, and hands you the answer your larger competitor pays a department to produce.
Your competitors have more analysts. They should not know more than you.
The announced ceiling and the money actually obligated are different fields in the same federal record. One lookup separates them.
A larger competitor runs functions you cannot afford to hire: a market intelligence desk, regulatory affairs, a capture team, a research group. That is the real gap. Not talent, not technology. Capacity to find and reconcile evidence.
Tensorust connects contracts, filings, grants, patents, research, regulation and corporate records into cited intelligence that smaller teams can act on immediately.
Your experts make the judgment. Tensorust eliminates the days spent finding and reconciling the evidence.
Each one is a defined deliverable built from primary records, with every figure linked back to the source and the coverage limits written in.
Where the larger competitor is actually exposed. Contracts approaching recompete, thin or expiring patent coverage, recalls and safety findings, published security exposure, lapsed registrations, quiet retreats from a segment. Every exposure tied to the record that shows it.
What the market actually looks like before you commit to it. Who holds the contracts, which agencies and buyers are active, what the standards require, who the incumbents are, and where public money is already moving.
Federal and institutional buying activity in your category. Who won, how much was actually obligated against the announced ceiling, when the recompete lands, and which offices buy the thing you make.
The standards, rulemaking, agency programs and funding lines that open or close a window for your technology, tracked continuously, so a change reaches you while you can still act on it.
Test what a competitor says in public against what the record shows. Announced contract value against dollars actually obligated. Claimed approvals against the regulatory record. Claimed scale against filings. Supported, overstated, or missing context, with the evidence attached.
Institutional-quality diligence on a company or a sector without an institutional research operation. Assembled from primary records, with the limits stated plainly so a partner can rely on it in an investment committee.
The cited evidence a conservative buyer needs before adopting something new: the research base behind the technology, federal validation and funding, standards position, and comparable public deployments. Built to be handed directly to a skeptical customer.
The department that keeps running. Funding, standards, policy, contract and competitor changes in your category, delivered on a cadence, so nobody on your team loses days searching for something that moved last week.
We do not sell to "manufacturers" or "biotech." We sell to the person below, who needs one particular slice of the public record and does not have a research team to assemble it. If this is your exact seat, we already know the datasets your answer lives in.
| # | The exact seat | The record you need | Who buys |
|---|---|---|---|
| 01 | Recycled-composite and reclaimed-fiber startups | The DOE funding, standards activity and research base that proves recycled carbon and glass fiber is qualified to a conservative buyer. | Founder, commercial lead |
| 02 | FedRAMP-track security vendors under 200 people | Which agencies carry catalogued exploited exposure in your category, and which contract vehicles put a named buyer in a live window. | Founder, federal sales |
| 03 | Cell, gene and radioligand therapy developers | Which targets carry funded investigator momentum before the trial field crowds, corrected for shared-grant artifacts. | BD, strategy, medical affairs |
| 04 | Class II device and diagnostics companies | The predicate chain, each competitor's clearance route and decision code, and the enforcement history behind a 510(k). | Regulatory, product strategy |
| 05 | Single-NAICS federal contractors and capture teams | Recompetes in your codes expiring in the next 18 months where the incumbent under-delivered against its ceiling. | Capture lead, BD |
| 06 | Search funds and lower-middle-market industrial PE | Institutional-grade diligence on one industrial target: contracts, patents, filings, recalls and lapses, without an institutional research desk. | Searcher, principal |
| 07 | Public-affairs and regulatory boutiques | The lobbying spend, rulemaking dockets and comment-letter record behind a client's specific fight, assembled overnight. | Managing partner, practice lead |
| 08 | Foreign industrial firms entering US federal markets | The contracts, standards, agencies and incumbents that define the one US market you are entering, mapped from public records. | US expansion lead |
The pattern. Usually between 5 and 200 employees, in a niche narrow enough that no analyst firm covers it properly. Selling into a market that is regulated, procurement-driven, standards-bound, or technically conservative. Facing a competitor with many times the staff. The record that answers your question is already public and specific to your niche. We show you that record. Reaching it is the problem Tensorust solves.
These come from live public records. The data was already public. The advantage comes from joining the right records and knowing what the fields actually mean.
Paste a claim, a headline, or a contract announcement. We search federal contracts, filings, lobbying and grants, then return the evidence receipt.
Open the investigatorFederal lobbying set against federal contract dollars, company by company. Useful for understanding who is shaping the rules in your category.
Open the radarThese were not written as reports. Each is a prototype of an outsourced evidence department: the days of first-pass work a larger competitor's staff would have done internally, already assembled and cited.
Twenty common absolute claims in composites recycling, tested against cited Crossref and U.S. DOE records, with a transparent decision and stated limits for each claim. The kind of packet that ends an argument with a conservative buyer.
A cited snapshot of where the field is actually active, which institutions lead it, and which work merits deeper review before a technical bet.
A cited public-record landscape for locating research momentum, visible institutions, technical themes, and the papers worth opening first.
A four-page decision packet that turns a broad question into an auditable starting point: activity, leaders, institutions, topics, and direct source links.
A research-leadership and momentum packet for scoping an emerging platform area without treating publication volume as a commercial conclusion.
A cited sample showing the research and institution signals a small team can use to frame deeper diligence on a platform bet.
Each packet is a starting point for a defined competitive question, not a claim of exhaustive coverage or a substitute for your own domain judgment. We build these for any market, technology, competitor set, or region.
Every engagement starts with a free cited sample so you can check the evidence before you commit. Prices are starting points. The scope, meaning depth, sources, competitor set and cadence, sets the quote.
One decision, one page, fully cited. We do the first-pass public-record work for a live question your team is facing right now.
One competitor, one set of public claims, tested against the record. Supported, overstated, or missing context, with every figure linked.
A full scoped deliverable, about one to two weeks:
Multi-source diligence on a company or sector for a major decision. Custom scope, quoted to the work, built to hold up in an investment committee.
Continuous coverage of funding, standards, policy, contracts and competitor movement in your category. Includes the Regulatory Window Monitor. Available after a first engagement.
| Option | Published hourly benchmark | Illustrative 5-hour allocation |
|---|---|---|
| External research support (contract analyst) | $100 to $400 per hour | $500 to $2,000 |
| Tensorust Competitor Claim Audit | Flat price | $299 |
The five-hour figure is a simple staffing illustration, not a consultant quote or a claim that every manual assignment takes five hours. NIH's life-sciences guide lists $100 to $200 per hour for foundational data collection and research support, and $200 to $400 for mid-level consultants. A separate medical-communications guide lists medical-strategy contractors at $130 to $160 per hour. These are life-sciences benchmarks; rates in other sectors vary by scope, seniority and geography. NIH SEED rate guide · EPM Scientific medical-communications guide
Life-sciences teams can also buy a self-serve cited research-leader brief for $149, delivered automatically. Need something else? Ask for a custom quote.
Tell us the fight you are in. We will send back a one-page cited packet built from primary records, so you can judge the evidence before you spend anything.
Tensorust already carries cited research-leader maps across 59 therapeutic areas and a live preview you can run right now. Enter a topic and get research leaders, institutions and active subtopics in seconds.
Founder and engineer. I built the evidence engine and every tool on this site, in public. When you hire Tensorust you are not buying a seat in a platform. You are getting a real person who will go find the record, and every number traces to a source you can open yourself.
Send the market, the competitor, or the decision in front of you. We will send back a short cited sample and scope what your team would spend in hours to assemble it by hand.
Or write directly: mattbusel@gmail.com
Your data stays yours. Tensorust reads only public government, corporate and scholarly records. We store no private data, and nothing you tell us about your market is sold, shared, or used to train anything.